Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 8Hyperandrogenism 3Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Progesterone Resistance 1Osteoporosis 1Obesity 1Hot Flashes 1Breast Neoplasms 1Anovulation 1

Interventions

Metformin 4Progesterone 3Inositol 2Folic Acid 2Estradiol 2bicalutamide 1Yoga 1Thioctic Acid 1Spironolactone 1Phlebotomy 1Ovidrel 1Magnesium 1Lactalbumin 1Flutamide 1Ethinyl Estradiol 1Estrogens 1Dexamethasone 1Cyproterone Acetate 1Carnitine 1Bloodletting 1Blood Donation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Hyperandrogenism × Progesterone × Clear all
NCT01427595 2021-01-08

Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

University of Virginia

Phase NA Completed
25 enrolled 6 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01428193 2018-06-04

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

University of Virginia

Phase NA Terminated
4 enrolled 5 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03088046 2017-03-23

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

Fundacion Dexeus

Phase NA Completed
15 enrolled

Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡